Market Place
Sourcing Support
Fractyl Health Wraps Up REMAIN-1 Pivotal Cohort Randomization
26 Feb 2026 //
GLOBENEWSWIRE
Fractyl`s REMAIN-1 Data Shows Revita Ensures Weight Maintenance
29 Jan 2026 //
GLOBENEWSWIRE
Fractyl Health Poised for Catalyst-Rich 2026 Post-GLP-1 Growth
05 Jan 2026 //
GLOBENEWSWIRE
Fractyl Health Shows Sustained Weight Maintenance Post Revita
02 Dec 2025 //
GLOBENEWSWIRE
Fractyl Health Unveils Strong Preclinical Data On RJVA-002
07 Oct 2025 //
GLOBENEWSWIRE
Fractyl Delivers Data On Its Device For Glp-1 Weight Maintenance
30 Sep 2025 //
FIERCE BIOTECH
Fractyl Health Closes $23M Underwritten Public Offering
07 Aug 2025 //
GLOBENEWSWIRE
Fractyl Health Announces Proposed Public Offering
05 Aug 2025 //
GLOBENEWSWIRE
Fractyl Health Reveals Preclinical Rejuva GLP-1 Obesity Data
23 Jun 2025 //
GLOBENEWSWIRE
Fractyl Health to Present New Data at ADA`s 85th Sessions
13 Jun 2025 //
GLOBENEWSWIRE
Fractyl Health Advances Rejuva® Gene Therapy in Europe for T2D
19 May 2025 //
GLOBENEWSWIRE
Fractyl Health Reveals Rejuva® Smart GLP-1™ Pancreatic Gene Therapy
17 May 2025 //
GLOBENEWSWIRE
Fractyl Health Partners Forge for Rejuva Gene Therapy
14 May 2025 //
CONTRACTPHARMA
Forge Biologics partners with Fractyl Health for AAV Development
14 May 2025 //
BUSINESSWIRE
Fractyl Health to Present Preclinical Data at ASGCT 2025 Meeting
28 Apr 2025 //
GLOBENEWSWIRE
Fractyl Health Expands Focus On Revita And Rejuva Programs
31 Jan 2025 //
GLOBENEWSWIRE
Fractyl Health Presents Pancreatic Gene Therapy Data At WCIRDC
12 Dec 2024 //
GLOBENEWSWIRE
Fractyl to Present Preclinical Data on Rejuva Therapy at WCIRDC
09 Dec 2024 //
GLOBENEWSWIRE
Fractyl Health Presents Preclinical Data on Rejuva® Gene Therapy
04 Nov 2024 //
GLOBENEWSWIRE
Fractyl Health to Present at Chardan’s Genetic Medicines Conference
24 Sep 2024 //
GLOBENEWSWIRE
Fractyl Presents GLP-1 Pancreatic Gene Therapy Data At DDW
20 May 2024 //
GLOBENEWSWIRE
Fractyl Announces Nomination of RJVA-001 as First Candidate in Gene Therapy Platform
05 Jan 2024 //
GLOBENEWSWIRE
Hoping its GLP-1 gene therapy can beat Wegovy, Fractyl plans IPO
15 Dec 2023 //
FIERCE BIOTECH
Fractyl Health files for IPO to back gene therapy
14 Dec 2023 //
ENDPTS
Fractyl Health Expands Landmark Academic-Industry Collaboration
16 Nov 2023 //
GLOBENEWSWIRE
Fractyl`s GLP-1 obesity gene therapy outdoes semaglutide—in mice
05 Oct 2023 //
FIERCE BIOTECH
Fractyl Health Demonstrated Improvement in Weight Loss in Studies of its Rejuva
04 Oct 2023 //
BUSINESSWIRE
Fractyl Health Unveils Results for its Rejuva® Pancreatic Gene Therapy Platform
18 May 2023 //
BUSINESSWIRE
